TABLE 2.

Adjusted Probability Estimates of 1-, 3-, and 5-Year Survival Among Persons Diagnosed With AIDS Before and After the Introduction of Highly Active Antiretroviral Therapy: Chicago, 1993–2001

	Pre-HAART Era, 1993–1995			HAART Era, 1996–2001
Characteristic	1 Year	3 Years	5 Years	1 Year	3 Years	5 Years
Gender
Male	0.81	0.58	0.51	0.86	0.77	0.72
Female	0.78	0.55	0.49	0.88	0.82	0.77
Race/ethnicity
Non-Hispanic Black	0.78	0.54	0.46	0.87	0.79	0.73
Non-Hispanic White	0.79	0.56	0.52	0.90	0.86	0.83
Hispanic	0.80	0.59	0.55	0.88	0.83	0.79
Mode of transmission
Male-to-male sexual contact	0.77	0.53	0.48	0.90	0.85	0.81
Injection drug use	0.79	0.57	0.49	0.86	0.77	0.70
Heterosexual contact	0.85	0.59	0.53	0.90	0.83	0.78
Age at diagnosis, y
13–29	0.85	0.60	0.53	0.92	0.87	0.81
30–49	0.78	0.56	0.49	0.89	0.82	0.77
≥ 50	0.68	0.45	0.41	0.76	0.66	0.63
Total	0.78	0.55	0.49	0.88	0.81	0.76

Note. HAART = highly active antiretroviral therapy.